Loading...
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.
RGEDF•PNK
HealthcareMedical - Pharmaceuticals
$27.17
$0.00(0.00%)
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (RGEDF) Financial Performance & Statements
Review Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
6.51%
↑ 6.51%
Operating Income Growth
35.28%
↑ 35.28%
Net Income Growth
50.61%
↑ 50.61%
Operating Cash Flow Growth
140.18%
↑ 140.18%
Operating Margin
29.98%
↑ 29.98%
Gross Margin
68.00%
↑ 68.00%
Net Profit Margin
27.90%
↑ 27.90%
ROE
19.61%
↑ 19.61%
ROIC
18.008%
↑ 18.008%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (RGEDF) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $221.12B | $216.73B | $216.26B | $203.43B |
| Cost of Revenue | $70.02B | $69.06B | $74.14B | $61.23B |
| Gross Profit | $151.10B | $147.67B | $142.12B | $142.20B |
| Gross Profit Ratio | $0.68 | $0.68 | $0.66 | $0.70 |
| R&D Expenses | $29.002B | $24.88B | $22.64B | $22.73B |
| SG&A Expenses | $62.25B | $51.12B | $55.48B | $52.08B |
| Operating Expenses | $91.39B | $76.76B | $79.24B | $78.60B |
| Total Costs & Expenses | -$161.42B | -$145.82B | $153.38B | $139.82B |
| Interest Income | $36.82B | $31.47B | $25.38B | $27.14B |
| Interest Expense | $29.73B | $27.68B | $16.76B | $11.52B |
| Depreciation & Amortization | $13.20B | $13.03B | $8.99B | $11.57B |
| EBITDA | $120.98B | $108.22B | $74.95B | $75.17B |
| EBITDA Ratio | $0.55 | $0.50 | $0.35 | $0.37 |
| Operating Income | $59.71B | $70.91B | $62.88B | $63.61B |
| Operating Income Ratio | $0.27 | $0.33 | $0.29 | $0.31 |
| Other Income/Expenses (Net) | $18.35B | -$25.63B | $11.48B | $18.66B |
| Income Before Tax | $78.05B | $45.28B | $74.36B | $79.23B |
| Income Before Tax Ratio | $0.35 | $0.21 | $0.34 | $0.39 |
| Income Tax Expense | $14.95B | $8.78B | $4.09B | $13.73B |
| Net Income | $63.97B | $37.06B | $70.00B | $68.22B |
| Net Income Ratio | $0.29 | $0.17 | $0.32 | $0.34 |
| EPS | $348.00 | $203.00 | $382.92 | $373.00 |
| Diluted EPS | $348.00 | $203.00 | $382.92 | $373.00 |
| Weighted Avg Shares Outstanding | $183.82M | $182.56M | $182.80M | $182.89M |
| Weighted Avg Shares Outstanding (Diluted) | $183.82M | $182.56M | $182.80M | $182.89M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan